PLAINSBORO, N.J., Jan. 28, 2025 /PRNewswire/ -- Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved Ozempic to...
Vous n'êtes pas connecté
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing kidney failure risk, disease progression, and death due to heart problems in diabetes patients with chronic kidney disease. This approval marks Ozempic as the first GLP-1 treatment option for type 2 diabetes and chronic kidney disease, after showing a 24% reduction in death and major cardiac events.
PLAINSBORO, N.J., Jan. 28, 2025 /PRNewswire/ -- Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved Ozempic to...
WEDNESDAY, Jan. 29, 2025 -- A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans at risk...
TUESDAY, Feb. 4, 2025 -- The U.S. Food and Drug Administration (FDA) has approved the first-ever clinical trials testing pig kidney transplants in...
Drinking 3-5 cups of tea daily can reduce mortality risk in patients with chronic kidney disease, especially in the early stages.
Managing diabetes becomes even more important as we age. For seniors, a healthy diet can make a big difference in controlling blood sugar, maintaining...
Managing diabetes becomes even more important as we age. For seniors, a healthy diet can make a big difference in controlling blood sugar, maintaining...
People with type 2 diabetes are more likely to develop serious health problems like heart disease, strokes, heart failure, and kidney disease. These...
Diabetes and high blood pressure (hypertension) are two of the most common health problems worldwide. They increase the risk of serious conditions...
AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with unresectable or...
People on hemodialysis for kidney failure often struggle with chronic pain, which is challenging to manage with opioids and other standard...